Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're searching to buy the Wegovy 0.5mg step-up dose, the straightforward answer is this: in the UK, semaglutide is a prescription-only medicine, and moving to 0.5mg from your starter dose requires a clinical review before any pharmacy can lawfully dispense it. That review isn't a formality — it's the mechanism that keeps dose progression safe. At nume, a GPhC-registered Independent Prescriber reads your answers and health information personally, the same day you submit, and confirms whether the step up is appropriate for you before anything is dispatched.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is something along the lines of: "I've finished my first Wegovy pen, can I just order the 0.5mg now?" The assumption is that stepping up is automatic once a certain time has passed. It isn't. Wegovy (semaglutide) is a Prescription-Only Medicine under UK law, and each dose change requires a fresh clinical assessment. That rule exists for a practical reason: how someone's body responds to 0.25mg tells a prescriber a great deal about how ready they are for the next step. GI side effects that haven't settled, unexpected changes in blood pressure, or other health developments all factor into the decision. The NHS semaglutide page sets out this titration framework clearly. Moving up without that review isn't just technically unlawful, it removes the safety net that makes the progression medically sensible in the first place.
What this means practically: any seller offering you the 0.5mg pen without asking for health information and providing a prescription is operating outside UK regulations. The MHRA has warned publicly about counterfeit and illegally supplied weight-loss pens, including seizures of fake products that contained substances other than what was advertised. If a price looks implausibly low or a seller is offering these medicines without a prescription, those are red flags. You can report suspect sellers directly via the MHRA Yellow Card scheme.
The lawful route in the UK runs through a registered prescriber and a GPhC-registered pharmacy. You can verify any online pharmacy at the GPhC register, nume's premises registration number is 9012878, which you can look up directly. The process itself is more straightforward than many people expect. You complete a free online consultation, providing your current health picture, how you've tolerated the 0.25mg starter phase, and any relevant medical history. A prescriber reviews that information personally. If the step up to 0.5mg is clinically appropriate, a prescription is issued and the medicine is dispensed from our GPhC-registered pharmacy, sourced through the licensed UK supply chain from Novo Nordisk authorised routes.
For those who are just starting out rather than stepping up, the 0.25mg starting dose follows the same process but without prior treatment history to provide. Either way, the consultation is free and there is no obligation before you speak with our team. If you want to understand how the full Wegovy titration pathway works from the beginning, the Wegovy treatment overview covers each phase in detail.
Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present) conditions such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't determine approval; the prescriber considers your full clinical picture, including how you've managed on the starter dose.
For the 0.5mg step specifically, the key questions are whether you've completed at least four weeks at 0.25mg, how your tolerance has been, and whether there's anything in your current health status that would give reason to pause. People transferring from another provider will be asked for evidence of their current treatment, this is standard practice at a legitimate clinic and a sign of responsible prescribing, not bureaucracy. The 0.5mg availability page has current stock information, and our FAQs page addresses common questions about the transfer process. NICE's appraisal of semaglutide for weight management (TA875) outlines the broader eligibility framework that informs clinical decisions in this space.
The 0.5mg dose sits in the middle of Wegovy's titration schedule. Most people remain at each level for approximately four weeks before a further review determines whether to progress. The maintenance doses are higher, and reaching them takes time, that's by design, not inconvenience. Rushing the progression tends to produce more pronounced side effects without meaningfully better outcomes in the short term.
When you're ready to consider the next step, the process repeats: a clinical review, confirmation that tolerance has been good, and a new prescription. If you'd like to buy Wegovy 0.5mg through our regulated service, the same straightforward consultation pathway applies, with a prescriber reviewing your case before anything is dispensed. If you want to explore what the full private treatment route involves before committing to anything, our treatment page lays out everything that's included (consultation, prescription, delivery and ongoing clinical support) with no subscription and no auto-renewal. Every repeat order is reviewed individually, and when you're ready to move on to the 1mg step-up dose, our team is on hand to guide you through each step of the process. That's how it works at a service that takes the prescribing part seriously.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.